$WIX Balance Sheet | Understand Stock

$WIX

$79.19 -$1.19 (1.48%) Close

$WIX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q4 FY2024 As of Dec 31, 2025	Q4 FY2023 As of Dec 31, 2024	Q4 FY2022 As of Dec 31, 2023	Q4 FY2021 As of Dec 31, 2022	Q4 FY2020 As of Dec 31, 2021	Q4 FY2019 As of Dec 31, 2020	Q4 FY2018 As of Dec 31, 2019	Q4 FY2017 As of Dec 31, 2018	Q4 FY2016 As of Dec 31, 2017	Q4 FY2015 As of Dec 31, 2016	Q4 FY2014 As of Dec 31, 2015	Q4 FY2013 As of Dec 31, 2014	Q4 FY2012 As of Dec 31, 2013
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Restricted cash
Short-term deposits
Restricted deposits
Marketable securities
Trade receivables
Prepaid expenses and other current assets
Total current assets
LONG-TERM ASSETS:
Prepaid expenses and other long-term assets
Property, Plant and Equipment, Net
Equity Method Investments
Marketable securities
Long-term assets
Intangible assets, net
Goodwill
Operating Lease, Right-of-Use Asset
Total long-term assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' DEFICIENCY
CURRENT LIABILITIES:
Trade payables
Employees and payroll accruals
Deferred revenues
Current portion of convertible notes, net
Accrued expenses and other current liabilities
Operating lease liabilities
Total current liabilities
LONG-TERM LIABILITIES:
Convertible Notes Payable, Noncurrent
Deferred revenues
Long-term deferred tax liabilities
Long-term liabilities
Long-term loan
Other long-term liabilities
Operating lease liabilities
Total long-term liabilities

Total liabilities
Commitments and contingencies
SHAREHOLDERS' DEFICIENCY:
Ordinary shares of NIS 0.01 par value - Authorized: 500,000,000 shares at December 31, 2025 and 2024; Issued 67,143,958 and 64,718,465 shares at December 31, 2025 and 2024, respectively; Outstanding: 54,989,523 and 56,107,932 shares at December 31, 2025 and 2024, respectively
Additional paid-in capital
Treasury shares at cost, 12,154,435 ordinary shares as of December 31, 2025 and 8,610,533 as of December 31, 2024
Accumulated other comprehensive income
Accumulated deficit
Total shareholders' deficiency
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIENCY
Common stock, par or stated value per share (in USD per share)
Common stock, shares authorized (in shares)
Treasury Stock, Common, Shares
Entity Common Stock, Shares Outstanding
Common stock, shares outstanding (in shares)
Common stock, shares issued (in shares)

Comments